| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414775A2 Novel bicyclic and tricyclic cannabinoids |
| 05/06/2004 | EP1414524A1 Treatment of hair follicle with neurokinin 1 receptor antagonists |
| 05/06/2004 | EP1414487A2 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414473A1 Oral compositions for the treatment of scalp disorders |
| 05/06/2004 | EP1414466A1 Combinations for the treatment of inflammatory disorders |
| 05/06/2004 | EP1414460A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414454A1 Paroxetine glycyrrhizinate |
| 05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414431A2 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| 05/06/2004 | EP1414430A2 5-aminolevulinic acid and esters, in combination with another photosensitiser, as photosensitising agents in photochemotherapy, and their uses in treating wounds |
| 05/06/2004 | EP1414429A2 Dermatological preparations containing an nsaid |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414426A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 05/06/2004 | EP1414405A1 Invert emulsion containing dhea |
| 05/06/2004 | EP1414402A1 Cosmetic or dermatological preparations containing a combination of creatinine and/or creatinine derivatives and creatine and/or the derivatives thereof |
| 05/06/2004 | EP1414401A1 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations |
| 05/06/2004 | EP1414399A2 Cosmetic composition and method of treating skin |
| 05/06/2004 | EP1414390A1 Nanocapsules containing a steroid for cosmetic compositions |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1098626B1 Method for regulating hair growth |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | EP0871466B1 Linear and cyclic peptides for the treatment or prevention of eczema/dermatitis |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/06/2004 | CA2500836A1 Metal-containing materials, compositions and methods |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494526A Inhibitor of monoamine uptake |
| 05/05/2004 | CN1494431A Stable enzymatic wound debrider |
| 05/05/2004 | CN1494429A Aguatic animal treatment method and composition containing pimenta extract |
| 05/05/2004 | CN1493354A External use Chinese medicinal ointment for treating burn and its preparation method |
| 05/05/2004 | CN1493329A Chinese medicinal liquid for treating limb dermatomycosis |
| 05/05/2004 | CN1493316A Medicinal composition for treating burn and its preparation process |
| 05/05/2004 | CN1493313A Extraction method of orostachys fimbriatus effective component |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1493271A Pox eliminating patch removing whithening and beautifying cream |
| 05/05/2004 | CN1493270A Composition of component of skin whitening cosmetics |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148223C Enopeptin containing compound preparation and its medical use for controlling sutaneous pigmentation |
| 05/05/2004 | CN1148219C Chinese medicine for curing dermatosis and its production method |
| 05/05/2004 | CN1148216C Medicine for curing acne and sore |
| 05/05/2004 | CN1148209C External use plaster for removing poison, alleviating pain and removing necrotic tissue |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/04/2004 | US6730703 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 05/04/2004 | US6730696 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | US6730655 Biphenyl diquaternary ammonium compounds |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730476 Methods of diagnosing early-onset menopause |
| 05/04/2004 | US6730299 Kit; simple, practical; bioresorbable, nontoxic wound protection; biocompatible fluid and gas; produces foam |
| 05/04/2004 | CA2069600C Fatty acid compositions |
| 04/29/2004 | WO2004035740A2 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035572A1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n’-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 04/29/2004 | WO2004035055A1 Use of dopamine receptor agonists for the treatment of cutaneous tumors, warts, and scars |
| 04/29/2004 | WO2004034958A2 Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2004000230A3 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2003005966A9 Topical medicine and process and apparatus for making same |
| 04/29/2004 | WO2003003004A3 Method for identifying compounds the specifically deplete mast cells |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | US20040083001 Intervertebral disc |
| 04/29/2004 | US20040082807 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082802 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082789 Thieno[2,3-c]iosquinolines for use as inhibitors of parp |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082666 Antiserotonine agents |
| 04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 04/29/2004 | US20040082661 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 04/29/2004 | US20040082634 Using allantoin; skin disorders, antiulcer agents, antiinflammatory agents |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |